Project Type: Science & Research
Value: £25 million
The project comprises the first phase (9150m2) of a new 60,000m2 science park development located at the GlaxoSmithKline R&D site at Stevenage.
Phase 1 of the project provides two new research buildings, an Incubator Facility and an Accelerator Building together with hard and soft landscaping, car parking and delivery areas.
The 5,050m2, 4 storey Biosciences Incubator Facility is designed to accommodated a number of bioscience start-up / spin-out companies.
The 4100m2, 3 storey Accelerator Building is designed to accommodate a handful of post-incubation / developing biosciences companies.
Both buildings are designed to achieve a BREEAM rating of ‘Excellent’ by including large building integrated photovoltaic walls, air source heat pumps, grey water harvesting, passive cooling, central atrium / light wells etc.